PHS
HOLX

PFM Health Sciences’s Hologic HOLX Stock Holding History

PFM Health Sciences’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-211,986
Closed -$13.8M – 79
2025
Q2 		$13.8M Buy
+211,986
New +$12.7M 1.18% 28
2020
Q4 		– Sell
-272,193
Closed -$18.1M – 91
2020
Q3 		$18.1M Sell
272,193
-341,583
-56% -$21.6M 0.84% 44
2020
Q2 		$35M Buy
+613,776
New +$30.1M 1.81% 18
2018
Q3 		– Sell
-1,892,703
Closed -$75.2M – 126
2018
Q2 		$75.2M Buy
1,892,703
+319,846
+20% +$12.3M 1.18% 26
2018
Q1 		$58.8M Sell
1,572,857
-157,527
-9% -$6.37M 1.19% 29
2017
Q4 		$74M Buy
+1,730,384
New +$69M 1.75% 20
2017
Q2 		– Sell
-1,213,261
Closed -$51.6M – 98
2017
Q1 		$51.6M Buy
1,213,261
+159,474
+15% +$6.5M 1.29% 28
2016
Q4 		$42.3M Buy
+1,053,787
New +$40.7M 1.19% 28
2016
Q3 		– Sell
-1,175,350
Closed -$40.7M – 93
2016
Q2 		$40.7M Buy
1,175,350
+720,862
+159% +$25M 1.23% 38
2016
Q1 		$15.7M Sell
454,488
-962,240
-68% -$33.6M 0.48% 51
2015
Q4 		$54.8M Buy
1,416,728
+13,290
+0.9% +$517K 1.67% 27
2015
Q3 		$54.9M Sell
1,403,438
-520,324
-27% -$20.6M 1.54% 24
2015
Q2 		$73.2M Sell
1,923,762
-1,143,254
-37% -$40M 1.85% 18
2015
Q1 		$101M Sell
3,067,016
-234,800
-7% -$7.21M 2.79% 6
2014
Q4 		$88.3M Buy
3,301,816
+2,749,052
+497% +$71M 2.06% 15
2014
Q3 		$13.4M Buy
+552,764
New +$14M 0.31% 48

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

PFM Health Sciences's HOLX Position: Q3 2025 in Review

PFM Health Sciences sold out of Hologic (HOLX) in Q3 2025, closing a stake of 211,986 shares — an estimated $13.8M sold.

PFM Health Sciences first reported a position in HOLX in Q3 2014 and held it in 16 quarters. The position peaked at $101M in Q1 2015. 739 funds tracked by Wall St. Rank hold HOLX as of Q3 2025.

  • PFM Health Sciences reported no remaining Hologic position as of Q3 2025 after selling out during the quarter.
  • PFM Health Sciences sold 211,986 Hologic shares in Q3 2025, an estimated $13.8M.
  • PFM Health Sciences first reported a position in Hologic in Q3 2014 and held it in 16 quarters.
  • PFM Health Sciences's Hologic position peaked at $101M in Q1 2015.
  • 739 funds tracked by Wall St. Rank held Hologic as of Q3 2025.

Based on PFM Health Sciences's 13F filing for Q3 2025, filed 14 Nov 2025.